A combined genetic and bioinformatic analysis implicates the CDKN1A rs1059234 variant in differentiated thyroid carcinoma susceptibility
Authors:
- Elisangela de Souza TeixeiraETElisangela de Souza Teixeira
- Raquel Bueno BarbieriRBRaquel Bueno Barbieri
- Larissa Teodoro RabiLRLarissa Teodoro Rabi
- Karina Colombera PeresKPKarina Colombera Peres
- Janaina Luisa LeiteJLJanaina Luisa Leite
- Natassia Elena BufaloNBNatassia Elena Bufalo
- Laura Sterian WardLWLaura Sterian Ward
Open Access
- 1 January 2026
- journal article
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 70 (6) , 1-10
Abstract
Objective: To evaluate the association of CDKN1A (rs1801270 and rs1059234) and CDKN1B (rs2066827 and rs34330) polymorphisms with differentiated thyroid carcinoma (DTC) risk and to explore potential functional impacts through in silico analyses. Subjects and methods: This case-control study included 185 DTC patients and 236 healthy controls. Genotyping was performed using TaqMan® assays, and associations with DTC risk and clinicopathological features were assessed via logistic regression. Bioinformatic tools were used to predict the structural and regulatory effects of the studied [...] ABSTRACT Objective: To evaluate the association of CDKN1A (rs1801270 and rs1059234) and CDKN1B (rs2066827 and rs34330) polymorphisms with differentiated thyroid carcinoma (DTC) risk and to explore potential functional impacts through in silico analyses. Subjects and methods: This case-control study included 185 DTC patients and 236 healthy controls. Genotyping was performed using TaqMan® assays, and associations with DTC risk and clinicopathological features were assessed via logistic regression. Bioinformatic tools were used to predict the structural and regulatory effects of the studiedKeywords
This publication has 46 references indexed in Scilit:
- Cyclin D1 and p27 Expression as Prognostic Factor in Papillary Carcinoma of the Thyroid: Association with Clinicopathological ParametersCroatian Medical Journal, 2008
- p21 and p27: roles in carcinogenesis and drug resistanceExpert Reviews in Molecular Medicine, 2008
- No evidence that CDKN1B (p27) polymorphisms modify breast cancer risk in BRCA1 and BRCA2 mutation carriersBreast Cancer Research and Treatment, 2008
- E2F1-Regulated MicroRNAs Impair TGFβ-Dependent Cell-Cycle Arrest and Apoptosis in Gastric CancerCancer Cell, 2008
- I-Mutant2.0: predicting stability changes upon mutation from the protein sequence or structureNucleic Acids Research, 2005
- Association of Cyclin D1 Genotype with Breast Cancer Risk and SurvivalCancer Epidemiology, Biomarkers & Prevention, 2005
- SIFT: predicting amino acid changes that affect protein functionNucleic Acids Research, 2003
- Equipment Note MUPRO: A MULTIPURPOSE ROBOTInternational Journal of Neuroscience, 2002
- p27kip1 Expression Distinguishes Papillary Hyperplasia in Graves' Disease from Papillary Thyroid CarcinomaLaboratory Investigation, 2000
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993